Reagan-Udall Post-Market Drug Surveillance Initiative Could Address Patient Web Sites
This article was originally published in The Pink Sheet Daily
Executive Summary
The IMEDS project getting under way at the Reagan-Udall Foundation could eventually address methods for analyzing data on drug side effects that are available through patient networking sites and blogs, though initial efforts will focus on insurance claims data and electronic medical records.